Stay updated with breaking news from Cormedix Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
CorMedix Inc. (NASDAQ:CRMD – Get Free Report) was the target of a significant increase in short interest during the month of April. As of April 15th, there was short interest totalling 9,380,000 shares, an increase of 13.7% from the March 31st total of 8,250,000 shares. Based on an average daily volume of 587,000 shares, the […]
SG Americas Securities LLC bought a new stake in CorMedix Inc. (NASDAQ:CRMD – Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm bought 28,465 shares of the company’s stock, valued at approximately $107,000. Several other institutional investors also recently […]
MJP Associates Inc. ADV bought a new position in CorMedix Inc. (NASDAQ:CRMD – Free Report) during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor bought 25,000 shares of the company’s stock, valued at approximately $94,000. A number of other hedge funds […]
BERKELEY HEIGHTS, N.J., March 27, 2024 -- CorMedix Inc. , a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of...
CorMedix Inc. (NASDAQ:CRMD) Q4 2023 Earnings Call Transcript March 12, 2024 CorMedix Inc. misses on earnings expectations. Reported EPS is $-0.26 EPS, expectations were $-0.21. CorMedix Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good morning ladies and gentlemen, […]